CTI BioPharma Corp. (CTIC)
(Delayed Data from NSDQ)
$0.99 USD
+0.01 (1.49%)
Updated May 3, 2019 04:00 PM ET
After-Market: $0.99 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[CTIC]
Reports for Purchase
Showing records 1 - 20 ( 205 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Dropping Coverage
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Transferring Covaerage
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Compelling Disease Modifying Properties Differentiates Pacritinb
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Drugs
We are terminating coverage of CTI BioPharma Corp. due to the departure from the firm of the covering analyst.
Provider: H.C. WAINWRIGHT & CO., INC.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Bolstered Balance Sheet and Ready for PERSIST-2
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Drugs
ASCO Highlights Part 1-Our Thoughts from McCormick Place
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Pacritinib a Real Threat to Ruxolitinib
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Drugs
2015 ASCO Planner-Clinical Data to Keep -Da Bears- AwayThis report contains brief updates on the following: ADXS, AGEN, ARIA, CLSN, CTIC, HTBX, ONTY, SGEN, SPPI, STML, TGTX, THLD. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Industry: Medical - Drugs
1Q15 Update-ASCO Data Could Foreshadow PERSIST-2 Outcome; Revising PT
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Industry: Medical - Drugs
2015 AACR Meeting Highlights-Cancer Gets a Dose of Brotherly Love
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
What is the Street Missing Regarding PERSIST-1?
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Flawed Cross Study Comparisons Weighing on Stock, Buy the Weakness
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Industry: Medical - Drugs
4Q14 Update-Partners and Persistence Help to Achieve Milestones
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.